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Background: Behavioural Activation (BA) treatment effectively reduces symptoms of depression in adults and
is more cost-effective than more complex therapies. Two recent systematic reviews of BA for depression in
young people highlighted the need for more studies in this area.Methods: In order to evaluate the acceptabil-
ity of BA treatment for adolescents with depression and the feasibility of conducting a trial of this intervention
in Child and Adolescent Mental Health Services (CAMHS), 22 patients from across three sites were randomised
to BA or usual CAMHS care. Existing CAMHS staff were trained to deliver the manualised intervention via a
brief course. Following treatment, young people and their parents/carers were asked to complete a feedback
survey. Symptoms and functioning were assessed at 3- and 6-month follow-up. The trial was registered with
the ISRCTN Registry (ref: ISRCTN52147450; https://www.isrctn.com/). Results: Recruitment targets were
achieved through screening large numbers of CAMHS service users. Intervention adherence by the participat-
ing adolescents was high (median number of completed BA sessions was seven out of a total of eight). There
were tentative suggestions of improvements following treatment; a large change in a positive direction for
the BA group, but not for usual care, was observed by visual comparisons of mean scores on measures of
depression, self-esteem and functioning. No adverse events were reported. Conclusions: The findings suggest
that BA in this setting is acceptable and warrants evaluation via a fully powered randomised controlled trial.
Key Practitioner Message
What is known?
• Behavioural Activation (BA) can be delivered by nonspecialist practitioners to adults with depression in a
way that is both clinically and cost-effective.
• There is a lack of evidence relating to the application of BA to an adolescent population, particularly in a
UK context.
What is new?
• Self-referral and clinician-led recruitment approaches appear most feasible to recruit to a trial.
• The brief, manualised BA treatment for young people affected by depression in UK CAMHS was acceptable
to the participants receiving the intervention.
• The BA intervention could be delivered by a variety of staff in this setting, following a brief training course
and with appropriate supervision.
What is significant for clinical practice?
• Psychological therapies, such as BA, have the capacity to enhance clinical practice due to the brief, simple
nature of the interventions that can be harnessed by less experienced practitioners.
• Although the results from this study suggest that BA is promising, this treatment approach needs to be eval-
uated in this population via a fully powered randomised controlled trial in order to answer questions about
effectiveness.
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Introduction
Depression in young people is common, long-lasting and
disabling; often being associated with educational
absenteeism and underachievement, substance use and
abuse, violence, poor reproductive and sexual health
outcomes, self-harm and/or suicidality (Birmaher et al.,
1996; Finning et al., 2019; Thapar, Collishaw, Pine, &
Thapar, 2012). Behavioural Activation (BA) is a time-lim-
ited, collaborative psychotherapy, informed by beha-
viour theory. This is based upon the concept that
depression results from a loss of positive reinforcement-
that is, experiences that result in rewardmake repetition
of the action more likely (Kanter, Busch & Rusch, 2009).
In adults, BA is effective for depression and can be deliv-
ered more economically than other psychological thera-
pies (Richards et al., 2016). There is a need in clinical
services for brief, evidence-based interventions that can
be delivered effectively by a variety of multidisciplinary
practitioners. However, there is little published research
exploring BA as a treatment option for youth depression
in the UK (Martin & Oliver, 2019; Tindall et al., 2017).
We explored the feasibility and acceptability of conduct-
ing a trial of BA for adolescents with depression within
Child and Adolescent Mental Health Services (CAMHS).
Methods
This was a multicentre, parallel, randomised controlled feasibil-
ity trial.
Existing CAMHS staff (NHS band 4–7), from three community
CAMHS teams in the north-east of England, were trained to
deliver the manualised intervention via a three-day training
course. Staff within these teams were aligned to one of three
providers (Tier 2 [targeted], Tier 3 [specialist] or Learning Dis-
ability Services [LD]), all centrally commissioned and based
within the same sites. We recruited staff from Tier 2 and 3 but
not LD due to the reading age required for themanualmaterials.
The BA treatment was administered using a treatment manual
adapted during a previous study (Arnott, Kitchen, Ekers, Gega,
& Tiffin, 2020). Staff were required to pass a half-day compe-
tency assessment prior to treating patients in the study. Staff
were subsequently able to access monthly group supervision
and individual weekly telephone supervision with a BA special-
ist from the NHS Trust.
Participants were identified via a case note review or through
self/clinician referral from across the three CAMHS teams over
a period of seventeen months (March 2015–July 2016). Young
people (aged 12–17 years old) displaying symptoms of depres-
sion (who had not yet received psychotherapy and did not
require urgent care) were offered a structured diagnostic inter-
view to confirm depression status (the Schedule for Affective
Disorders and Schizophrenia for School-Age Children-Present
and Lifetime version [K-SADS-PL]; Kaufman et al., 1997). The
K-SADS-PL also includes a researcher-rated measure of func-
tioning (Children’s Global Assessment Scale [CGAS]). Additional
self-report measures of mood (Mood and Feelings Question-
naire- Child/Parent versions [MFQ-C/P]; Costello & Angold,
1988) and self-esteem (Rosenberg Self-Esteem Measure [RSE];
Rosenberg, 1965) were completed. Potential participants were
excluded if there was evidence of active substance abuse/de-
pendence.
Patients meeting the criteria for Major Depressive Disorder
[MDD] on the K-SADS-PL were offered the opportunity to partic-
ipate in the study. Informed consent (from young people aged
16–17 and parents/carers of those aged 12–15) or assent (from
young people aged 12–15) was obtained from all participants.
Participants were then assigned, individually, to treatment con-
ditions (BA or usual care) using a remote, blocked, telephone
randomisation process by an otherwise uninvolved member of
NHS staff. Randomisation was performed by an independent
statistician in blocks of eight and stratified according to depres-
sion severity (mild/moderate or severe) and setting (Tier 2 or 3).
The allocation sequence for the participating patients was con-
cealed from the researcher responsible for enrolling/assessing
the participants and was only revealed once allocation was com-
plete.
The comparison condition ‘usual care’ represents standard
care in CAMHS; participants received treatments deemed
appropriate by their CAMHS professional, and there were no
restrictions, protocol or extra training given. Clinicians in the
BA arm used the manual to implement BA for eight sessions;
other psychotherapies were restricted during this time but any
additional psychotherapy as deemed necessary was provided
following delivery of BA. Sessions of BA were designed to be
delivered face-to-face, spaced one week apart and lasting for
one hour. Parent/carer involvement in treatment was at the dis-
cretion of the participating young person. Where young people
invited their parents/carers to be involved, there was separate
intervention content for them to cover.
At 3-month postbaseline, the diagnostic interview was re-ad-
ministered and the additional outcome measures repeated
along with a bespoke treatment satisfaction survey. At 6-month
postbaseline, a telephone interview repeated selected outcome
measures (MFQ-C/P and RSE).
This study was approved by the Durham University School of
Medicine, Pharmacy and Health Research Ethics Sub-Commit-
tee (ref: ESC2/2014/14), the National Research Ethics Com-
mittee North East – Newcastle and North Tyneside 1 (ref: 15/
NE/0002) and the NHS Trust Research and Development Office
(ref: 0360/15). The trial was registered with the ISRCTN Regis-
try (ref: ISRCTN52147450; https://www.isrctn.com/).
Results
All study sites and the majority of staff (7/10) trained in
the BA intervention were retained throughout the trial
(one did not pass the competency assessment, one left
the service and another withdrew due to additional man-
agement responsibilities).
Participant recruitment required the screening of rela-
tively large numbers of young people (see Figure 1); 66%
of patients (53/80) identified by their clinicians and 75%
(3/4) of self-referrals met the study eligibility criteria,
compared with 3% (8/267) identified via the case note
review. Thirty-eight potential participants, provisionally
deemed eligible, were excluded prior to the initial diag-
nostic interview. One no longer met provisional inclusion
criteria, 15 had been discharged from CAMHS care,
three were transferred to a different part of the service,
10 declined after receiving study materials (one did not
like the weekly format, one did not wish to be ran-
domised, one did not like talking therapies, five declined
without providing a reason and two did not attend with-
out providing a reason). Nine were excluded by their clin-
ician; one clinician did not want researchers to approach
the patient, three felt the patient was too complex or the
BA treatment was too simple, one wanted to use the
patient as a case study for a training programme, one felt
another comorbidity (rather thanMDD) should be priori-
tised, one reported their patient required urgent care
and two clinicians felt group therapy was required.
Therefore, 26 progressed to K-SADS-PL assessment with
22 offered study entry (see Table 1 for baseline charac-
teristics).
Behavioural Activation was delivered by six clinicians
(mean caseload of 1.8 randomised patients); one clini-
cian was not allocated any patients during the study.
Most participants completed a high number of the
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prescribed BA sessions (mean 5.7; median 7). Although
not powered to demonstrate statistically or clinically sig-
nificant intergroup differences, descriptive study data
provided some tentative suggestions that BA may result
in improved outcomes compared with usual care (see
Table 2 for baseline, 3- and 6-month follow-up data,
Provisionally eligible (n = 64)
Excluded (n = 38)
Excluded by clinician (n = 9)
Discharged/transferred (n =18)
Declined to parcipate (n = 10)
No longer meets eligibility criteria (n = 1)
Lost to follow-up (n = 6)
Excluded (n = 1)
Withdrawn (n = 1)
Lost to follow-up (did not respond) (n = 4)
Lost to follow-up (n = 4)
Excluded (as above: n = 1)
Withdrawn (n = 1)
Lost to follow-up (did not respond) (n = 2)
Allocated to BA intervenon (n = 11)
Received allocated intervenon (n = 9)
Did not receive allocated intervention  (n=
2): one discharged from service and one 
removed due to risk by clinicians
Lost to follow-up (n = 3)
Lost to follow-up (did not respond) (n = 3)
Allocated to usual care (n = 11)
Received allocated intervenon (n = 9)
Did not receive allocated intervenon  (n = 
2): both discharged from service by 
clinicians (one returned to service later)
Lost to follow-up (n = 5)
Lost to follow-up (did not respond) (n = 5)
Randomised (n = 22)
Assessed for eligibility (n = 351)*
Excluded (n = 287)
Not meeng inclusion criteria (n = 286)
Declined to parcipate (n = 1)
Eligibility Assessed (n = 26)
Excluded (n = 4)
Not meeng inclusion criteria (n = 1)
Other reasons (n = 3)
Figure 1. CONSORT Diagram. *Identified by case note review (n = 267), study poster (n = 4) or clinician (n = 80)
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presented by treatment group). Fifteen participants
(68%) were able to be followed up at three months (BA
[7/11; 64%]; usual care [8/11; 73%]); in the usual care
arm 1/8 (13%) no longer met the criteria for MDD com-
pared with 4/7 (57%) in the BA arm. Improvements in
functioning were observed at 3-month follow-up (CGAS
scores improved by 10.74 points in the BA arm and
decreased by 3.5 in the usual care arm). Mean scores on
the MFC-C reduced in both study arms but more so for
those in the BA arm at 6-month follow-up (18.11 com-
pared with –8.88 MFQ-C points in the usual care arm
[18.83 on theMFQ-P in the BA arm and2 in the usual
care arm]). Similarly, self-esteem scores improved in
both arms but by a greater degree in the BA arm at 6-
month follow-up (RSE scores improved in the BA arm by
4.71 points and by 2.05 in the usual care arm). No
adverse events were recorded.
Following treatment, young people who received BA
were asked if they found it helpful; five (5/7) reported BA
was helpful to some degree whilst one did not find it
helpful (one did not receive treatment). Three (3/4) of
their parents found BA to be helpful to some degree, and
one did not. Free-text responses indicated one young
person who received BA treatment valued that their feel-
ings were acknowledged and that they were listened to
whilst also being given practical advice. One young per-
son liked that BA was based upon them helping them-
selves rather than having to rely upon other people.
Their parent found it helpful that BA focused upon
things their child used to enjoy and guided them in reviv-
ing those interests. Treatment was felt to be nonblaming;
helping their young person to realise it was not their
fault that they felt the way they did. Another young par-
ticipant reported that their BA practitioner was ‘lovely
and really helpful’ and that BA helped them a lot. This
young person’s parent liked the weekly format of the BA
sessions. Another parent found the BA treatment easy to
follow and understand. In response to the survey, six
young people reported they were happy to some degree
with the BA treatment received whilst one was ‘very
unhappy’. All four parents asked, were happy to some
degree with the BA treatment. In contrast, one parent
commented they ‘didn’t do much’ during BA. Another
parent felt they already knew most of what was taught
during the BA sessions.
Participants, parents and the assessor responsible for
conducting the diagnostic interviews were not blinded to
treatment allocation. The number and content of usual
care appointments were recorded inconsistently in
patient electronic records. Although fidelity checks
involving recording and independently assessing ther-
apy sessions were not completed in the study, we had in
place quality controls to minimise variance due to the
therapists delivering BA; we achieved this by ensuring
consistent intervention delivery through standardised
training and treatment materials, and ongoing supervi-
sion.
Discussion
This study demonstrates that it is possible to recruit
young people to a trial of BA in this complex service set-
ting. However, despite screening large numbers of case
notes, this recruitment method resulted in few poten-
tially eligible participants; the recruitment rate could
Table 1. Participant Baseline Characteristics as randomised




Female 9 (81.8) 9 (81.8)
Male 2 (18.2) 2 (18.2)
Age at consent, y:m
Mean (SD) 15:8 (1:5) 15:5 (1:0)
Median (range) 15:10 (13:11-17:7) 15:7 (13:8-16:10)
K-SADS-PL, No. (%)
No. (%) with data 11 (100) 11 (100)
Diagnosis*
MDD 11 (100) 11 (100)
Melancholic 4 (36.4) 4 (36.4)
Atypical 2 (18.2) 2 (18.2)
Severity
Mild 4 (36.4) 6 (54.5)
Moderate 3 (27.3) 2 (18.2)
Severe 4 (36.4) 3 (27.3)
Comorbidities*
No. (%) 11 (100) 11 (100)
Mean (SD) 4.55 (1.21) 3.64 (1.75)
Median (range) 5 (2-6) 4 (1-6)
Mania 1 (9.1) 1 (9.1)
Panic Disorder 4 (36.4) 4 (36.4)
Separation Anxiety Disorder 6 (54.5) 3 (27.3)
Avoidant Disorder/Social Phobia 6 (54.5) 5 (4.5)
Agoraphobia & Specific Phobias 3 (27.3) 2 (18.2)
Overanxious/Generalised
Anxiety Disorder
11 (100) 11 (100)
Anorexia Nervosa 1 (9.1) 1 (9.1)
Bulimia Nervosa 1 (9.1) 0 (0)
Attention Deficit Hyperactivity
Disorder
4 (36.4) 1 (9.1)
Oppositional Defiant Disorder 4 (36.4) 1 (9.1)
Conduct Disorder 4 (36.4) 4 (36.4)
Tic Disorders 1 (9.1) 1 (9.1)
Post-Traumatic Stress Disorder 4 (36.4) 6 (54.5)
MFQ-C scorea
No. (%) with data 11 (100) 11 (100)
Mean (SD) 33.91 (11.8) 35.55 (11.09)
Median (range) 34 (17-58) 35 (18-50)
MFQ-P scoreb
No. (%) with data 6 (100**) 7 (100**)
Mean (SD) 29.83 (7.36) 29 (8.58)
Median (range) 28 (23-42) 32 (16-38)
RSE scorec
No. (%) with data 11 (100) 11 (100)
Mean (SD) 11.09 (4.37) 12.45 (4.84)
Median (range) 11 (5-20) 13 (6-21)
CGAS scored
No. (%) with data 11 (100) 11 (100)
Mean (SD) 54.55 (9.47) 59.64 (6.8)
Median (range) 58 (30-65) 59 (50-68)
aMood and Feelings Questionnaire: Long Version Child Self-
Report (MFQ-C) score range, 0–66; higher scores indicate worse
mood.
bMood and Feelings Questionnaire: Long Version Parent Self-
Report (MFQ-P) score range, 0–68; higher scores indicate worse
mood.
cRosenberg Self-Esteem Measure (RSE) score range, 0–30; scores
between 15 and 25 are in the normal range, scores below 15 sug-
gest low self-esteem.
dChildren’s Global Assessment Scale (CGAS) score range, 1–100;
scores between 1–10 extremely impaired, 11–20 very severely
impaired, 21–30 severe problems, 31–40 serious problems, 41–50
obvious problems, 51–60 some noticeable problems, 61–70 some
problems, 71–80 doing alright, 81–90 doing well and 91–100
doing very well.
*Diagnostic categories/comorbidities are not mutually exclusive
(i.e. one participant may meet the criteria for multiple depres-
sion-types/comorbidities)
**100% of those asked; only those young people aged 15 and
under required parental consent to participate so only those par-
ents were asked to complete theMFQ-P.
© 2020 The Authors. Child and Adolescent Mental Health published by John Wiley & Sons Ltd on behalf of Association for Child and
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therefore be improved by focusing on clinician-led and
self-referral recruitment methods.
Participants’ session attendance rates were high, and
the BA intervention was viewed positively by most partic-
ipating young people and their families, indicating BA is
an acceptable treatment option for depression in this
context. To date, BA interventions have mainly been
evaluated using uncontrolled before and after compar-
isons. In the absence of a control group, lower ratings at
follow-up may merely reflect regression to the mean
effects but be wrongly attributed to the intervention. As
such, progression to pilot and future definitive ran-
domised controlled trials (RCTs) would greatly add to
knowledge in this area. We found a trend towards
greater improvements in mood, self-esteem and func-
tioning in those individuals who received BA compared
with usual care. In adults, BA is effective and cost-effec-
tive and can be delivered by trained therapists or
nonspecialist staff, as evidenced by the findings of RCTs
and meta-analyses (Ekers et al., 2011, 2014; Richards
et al., 2016). In adolescents, themost recent meta-analy-
sis of four RCTs on BA (Martin & Oliver, 2019) reported a
large effect in favour of BA versus controls (one active
intervention, one signposting and two no treatment) with
a pooled standardised mean difference of 0.70 (95% CI
1.20, 0.20). An earlier meta-analysis (Tindall et al.,
2017) combined the results of three RCTs, including an
unpublished PhD thesis. The pooled results favoured BA
over its comparators, estimating a moderate effect size
(pooled mean difference of 4.17), albeit with a wide
associated confidence interval (95% CI8.25,0.09).
A closer look at the five individual RCTs (one from
Japan and four from the US) included in the two meta-
analyses of BA for adolescents shows that: Takagaki
et al. (2016) included only 18- to 19-year-old university
students with subthreshold depression; Chu et al.
(2016) andWeering et al. (2017) included a range of diag-
noses apart from depression and reported global rather
than depression-specific outcomes; Stark (1985) only
included children aged 9–12 years; McCauley et al.
(2016) included 12–18 year olds and compared BA with
a suite of evidence-based interventions (e.g. cognitive
behavioural therapy) but it was underpowered to firmly
establish ‘equivalence’ of BA with ‘gold standard’ alter-
natives.
To our knowledge, this is the only European RCT of
BA for adolescents with a diagnosis of depression mea-
suring not only depression-specific outcomes but also
depression recovery against usual care in CAMHS. A
previous UK-based RCT (Goodyer et al., 2016) of psycho-
logical interventions for adolescents with major depres-
sion included a ‘brief psychosocial intervention’ that had
BA elements (action-orientated interpersonal and enjoy-
able activities), but did not claim to be BA, nor did it fol-
low a BA model. We recruited from a clinically referred
help-seeking sample and used limited exclusion criteria,
making our results relatively representative of the
CAMHS settings. Therapy was delivered by staff from the
setting, in the setting. The pragmatic approach to trial
design led to a comparison of viable, clinically relevant
alternative treatments, providing insight into the reali-
ties of delivering this treatment in a UK-based CAMHS
service.
Our trial involved three CAMHS teams, all based in
the north-east of England. This may limit the generalis-
ability of the results to other geographies. It was not pos-
sible to quantify or control for the contribution of
medication. We were unable to assess practitioner’s fide-
lity to the BA model. Nevertheless, our findings suggest
that this approach warrants robust evaluation via a fully
powered randomised clinical trial.
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